MedTrace Logo

Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers

NCT07063420 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-11-13

No results posted yet for this study

Summary

Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).

Conditions

  • Type 2 Diabetes Treated With Insulin

Interventions

OTHER

Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS)

Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) PCM-DSS

OTHER

Continuous Glucose Monitor (CGM) + Usual Care

Continuous Glucose Monitor (CGM) + Usual Care (Physician)

Sponsors & Collaborators

  • University of Virginia

    collaborator OTHER

  • Daniel Chernavvsky, MD

    lead OTHER

Principal Investigators

  • Ralf Nass, MD · University of Virginia Center for Diabetes Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-28
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07063420 on ClinicalTrials.gov